StephanieGregoryMD

PubMed

• Hereditary Hemochromatosis Manifesting After Treatment of Paroxysmal Nocturnal Hemoglobinuria With Eculizumab.
  Elizabeth Elliott, Salman Waheed, Sahr Syed, Sheila Eswaran, Stephanie A. Gregory, Jamile M. Shammo> ;Clinical Lymphoma, Myeloma & Leukemia. 2018 Jan 1
• 6 citations
  Phase 2 study of CHOP‑R‑14 followed by 90Y‑ibritumomab tiuxetan in patients with previously untreated diffuse large B‑cell lymphoma
  Reem Karmali, Melissa L. Larson, Jamile M. Shammo, Stephanie A. Gregory, Teresa O'Brien, Parameswaran Venugopal> ;Molecular and Clinical Oncology. 2017 Apr 1
• 3 citations
  CHOP Chemotherapy Followed by Tositumomab and Iodine-131 Tositumomab for Previously Untreated Diffuse Large B-cell Lymphoma.
  John P. Leonard, Stephanie A. Gregory, Hedy Smith, Thierry Horner, Vanessa C. Williams, Patricia Giampietro, Thomas S. Lin> ;Clinical Lymphoma, Myeloma & Leukemia. 2016 Apr 1
• 14 citations
  Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trial
  Andreas Bühler, Clemens-Martin Wendtner, Thomas J. Kipps, Laura Z. Rassenti, Graeme Fraser, Anne-Sophie Michallet, Peter Hillmen, Jan Dürig, Stephanie A. Gregory, Matt...> ;Blood Cancer Journal. 2016 Mar 11
• 104 citations
  Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus
  Meletios A. Dimopoulos, Efstathios Kastritis, Roger G. Owen, Robert A. Kyle, Ola Landgren, Enrica Morra, Xavier Leleu, Ramón García-Sanz, Nikhil C. Munshi, Kenneth C. ...> ;Blood. 2014 Aug 28
• 59 citations
  Active Idiotypic Vaccination Versus Control Immunotherapy for Follicular Lymphoma
  Ronald Levy, Kristen N. Ganjoo, John P. Leonard, Julie M. Vose, Ian W. Flinn, Richard F. Ambinder, Joseph M. Connors, Neil L. Berinstein, Andrew Belch, Nancy L. Bartle...> ;Journal of Clinical Oncology. 2014 Jun 10
• 12 citations
  Long-Term Follow-Up of R-CHOP With Bevacizumab as Initial Therapy for Mantle Cell Lymphoma: Clinical and Correlative Results
  Jia Ruan, Stephanie A. Gregory, Paul J. Christos, Peter Martin, Richard R. Furman, Morton Coleman, John P. Leonard> ;Clinical Lymphoma, Myeloma & Leukemia. 2014 Apr 1
• 20 citations
  Phase III safety study of rituximab administered as a 90-minute infusion in patients with previously untreated diffuse large B-cell and follicular lymphoma
  Shaker R. Dakhil, Robert C. Hermann, Marshall T. Schreeder, Stephanie A. Gregory, Marc Monte, Kevin S. Windsor, Deborah Hurst, Akiko Chai, Michael Brewster, Paul Richards> ;Leukemia & Lymphoma. 2014 Jan 29
• 15 citations
  Corrigendum to A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma ...
  Andrew M. Evens, Kenneth R. Carson, Jill M. Kolesar, Chadi Nabhan, I. Helenowski, Nahida Islam, Borko Jovanovic, Paul M. Barr, Paolo Caimi, Stephanie A. Gregory, Leo I...> ;Annals of Oncology. 2014 Jan 1
• 363 citations
  Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: ...
  Philippe Armand, Arnon Nagler, Edie Weller, Steven M. Devine, David Avigan, Yi Bin Chen, Mark S. Kaminski, H. Kent Holland, Jane N. Winter, James R. Mason, Joseph W. F...> ;Journal of Clinical Oncology. 2013 Nov 20
• 7 citations
  Ocular Adnexal MALTomas: Case Series of Patients Treated With Primary Radiation
  Wesley Alan Russell, Arnold M. Herskovic, David Gessert, Jack A. Cohen, Jonathan B. Rubenstein, Stephanie A. Gregory> ;Clinical Advances in Hematology & Oncology. 2013 Apr 1
• 4 citations
  Successful treatment of hepatosplenic T-cell lymphoma with ESHAP followed by autologous stem cell transplant.
  Anna W. Chalmers, Deborah A. Katz, Ira Miller, Stephanie A. Gregory> ;Clinical Advances in Hematology & Oncology. 2013 Feb 1
• 10 citations
  Aggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patients.
  Reem Karmali, Laura A. Paganessi, Robin R. Frank, Sucheta Jagan, Melissa L. Larson, Parameswaran Venugopal, Stephanie A. Gregory, Kent W. Christopherson> ;Journal of Leukocyte Biology. 2013 Jan 1
• 11 citations
  CD26 protease inhibition improves functional response of unfractionated cord blood, bone marrow, and mobilized peripheral blood cells to CXCL12/SDF-1
  Kent W. Christopherson, Robin R. Frank, Sucheta Jagan, Laura A. Paganessi, Stephanie A. Gregory, Henry C. Fung> ;Experimental Hematology. 2012 Nov 1
• 118 citations
  A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era.
  Andrew M. Evens, Irene Helenowski, Erika Ramsdale, Chadi Nabhan, Reem Karmali, Britt Hanson, Benjamin Parsons, Scott E. Smith, Annette Larsen, June M. McKoy, Borko Jov...> ;Blood. 2012 Jan 19
• 77 citations
  Analysis of very elderly (≥80 years) non-hodgkin lymphoma: impact of functional status and co-morbidities on outcome.
  Chadi Nabhan, Sonali M. Smith, Irene Helenowski, Erika Ramsdale, Benjamin Parsons, Reem Karmali, Josephine Feliciano, Britt Hanson, Scott E. Smith, June M. McKoy, Anne...> ;British Journal of Haematology. 2012 Jan 1
• 15 citations
  Safety and efficacy of combination therapy with fludarabine, mitoxantrone, and rituximab followed by yttrium-90 ibritumomab tiuxetan and maintenance rituximab as front...
  Reem Karmali, Mohamad Kassar, Parameswaran Venugopal, Jamile M. Shammo, Henry C. Fung, Robert Bayer, Teresa O'Brien, Stephanie A. Gregory> ;Clinical Lymphoma, Myeloma & Leukemia. 2011 Dec 1
• 9 citations
  Granulocyte-macrophage colony stimulating factor-induced immune priming of cyclophosphamide, doxorubicin, vincristine, and prednisone with rituximab chemoimmunotherapy...
  Reem Karmali, Melissa L. Larson, James E. Wooldridge, Stephanie A. Gregory, Teresa O'Brien, Jamile M. Shammo, Katherine Bueschel, Parameswaran Venugopal> ;Leukemia & Lymphoma. 2011 Oct 24
• 6 citations
  Relapsed diffuse large B-cell lymphoma--10 years later.
  Shikha Jain, Neel Shah, Stephanie A. Gregory> ;Clinical Advances in Hematology & Oncology. 2011 Sep 1
• 22 citations
  Clinical and laboratory features of myelofibrosis and limitations of current therapies.
  Stephanie A. Gregory, Ruben A. Mesa, Ronald Hoffman, Jamile M. Shammo> ;Clinical Advances in Hematology & Oncology. 2011 Sep 1
• 4 citations
  Multiple myeloma with multiple extramedullary plasmacytomas.
  Julie R. Nangia, Arti A Lakhani, Jerome Loew, Stephanie A. Gregory> ;Clinical Advances in Hematology & Oncology. 2011 Aug 1
• 30 citations
  Treatment recommendations for radioimmunotherapy in follicular lymphoma: a consensus conference report
  Thomas E. Witzig, Paul Fishkin, Leo I. Gordon, Stephanie A. Gregory, Samuel A. Jacobs, Roger M. Macklis, Peter McLaughlin, Oliver W. Press, Andrew D. Zelenetz> ;Leukemia & Lymphoma. 2011 Jun 23
• Multicenter analysis of more than 300 very elderly non-Hodgkin lymphoma (NHL) patients (pts): Impact of comorbidities and functional status on outcome.
  Nabhan C, Smith SM, Helenowski IB, Ramsdale EE, Karmali R, Parsons BM, Feliciano J, Hanson B, Smith SE, Mckoy JM, Larsen A, Hantel A, Gregory SA, Evens AM> ;J. Clin. Oncol.. 2011-05-20
• Etoposide and cytarabine as an effective and safe cytoreductive regimen for relapsed or refractory acute myeloid leukemia.
  Nair G, Karmali R, Gregory SA, Shammo JM, Fung HC, Jimenez A, Venugopal P, Larson ML> ;J. Clin. Oncol.. 2011-05-20
• 5 citations
  In vivo expansion of the megakaryocyte progenitor cell population in adult CD26-deficient mice
  Shannon Kidd, Carlos E. Bueso-Ramos, Sucheta Jagan, Laura A. Paganessi, Lisa N. Boggio, Henry C. Fung, Stephanie A. Gregory, Kent W. Christopherson> ;Experimental Hematology. 2011 May 1
• Join now to see all